Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
166
-
Total 13F shares, excl. options
-
58.4M
-
Shares change
-
-125K
-
Total reported value, excl. options
-
$7.85B
-
Value change
-
-$60.4M
-
Put/Call ratio
-
1.26
-
Number of buys
-
89
-
Number of sells
-
-73
-
Price
-
$134.53
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q4 2021
210 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q4 2021.
Ascendis Pharma A/S - ADR (ASND) has 166 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58.4M shares
.
Largest 10 shareholders include Artisan Partners Limited Partnership (7.94M shares), RA CAPITAL MANAGEMENT, L.P. (7.57M shares), FMR LLC (5.36M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.76M shares), BAKER BROS. ADVISORS LP (4.54M shares), WELLINGTON MANAGEMENT GROUP LLP (4.07M shares), JANUS HENDERSON GROUP PLC (3.22M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2.64M shares), Avoro Capital Advisors LLC (2M shares), and EVENTIDE ASSET MANAGEMENT, LLC (1.75M shares).
This table shows the top 166 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.